Search and Find

Book Title

Author/Publisher

Table of Contents

Show eBooks for my device only:

 

Neuropsychiatric Disorders

of: Koho Miyoshi, Yasushi Morimura, Kiyoshi Maeda

Springer-Verlag, 2010

ISBN: 9784431538714 , 346 Pages

Format: PDF, Read online

Copy protection: DRM

Windows PC,Mac OSX,Windows PC,Mac OSX geeignet für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Read Online for: Windows PC,Mac OSX,Linux

Price: 149,79 EUR



More of the content

Neuropsychiatric Disorders


 

Miyoshi_Frontmatter_O.pdf

2

Miyoshi_Ch01_O.pdf

16

Part I: Clinical Manifestations of Neuropsychiatric Disorders

17

Introduction

17

Neuropsychiatric Symptoms and Neuropsychiatric Disorders

18

Characteristics of Clinical Manifestations of Neuropsychiatric Disorders

19

Multiple Neuropsychiatric Symptoms Occur Simultaneously

19

Probable and Possible Symptoms of Neuropsychiatric Disorders

20

Neuropsychiatric Symptoms Could Be the Earliest Symptomsin Cerebral Disorders

21

Neuropsychiatric Symptoms Are Not Pathognomonic to a Certain Cerebral Disorder

22

Neuropsychiatric Symptoms May Mimic Endogenous Psychoses

22

Neuropsychiatric Symptoms and Syndromes

22

Anxiety and Neurotic Complaints

24

Apathy

24

Mood Disorder

24

Hallucinations and Delusions

25

Behavioral and Personality Changes

26

Delirium

26

Persistent Cognitive Impairment (Dementia)

26

Dementia of the Alzheimer Type

27

Neurodegenerative Dementias of Non-Alzheimer Type

27

Vascular Cognitive Impairment

28

Conclusions

28

References

29

Miyoshi_Ch02_O.pdf

30

Thyroid–Brain Interactions in Neuropsychiatric Disorders

31

Introduction

32

Thyroid Axis Hormone Secretion and Metabolism

32

Thyroid Hormone Transport to the Brain

33

Thyroid Hormone Receptors and Homeostasis in the Brain

33

Fetal Thyroid Economy and Development of the Brain

35

MCT-8 Mutations and Neurodevelopment

36

Hypothyroidism and Mental Function in Adults

36

Treatment of Hypothyroidism

37

Hyperthyroidism and Mental Symptoms in Adults

37

Treatment of Hyperthyroidism

38

Low T3 Syndrome in Mental Disorders

38

Thyroid Autoimmunity and Mood Disorders

38

Thyroid Function in Mood Disorders

39

Thyroid Abnormalities and Schizophrenia

39

Thyroid Axis Hormones in Treatment of Mental Disorders

40

Thyroid Hormones

40

Thyrotropin-Releasing Hormone

40

Conclusion

41

References

41

Miyoshi_Ch03_O.pdf

45

Lack of Insight and Awareness in Schizophrenia and Neuropsychiatric Disorders

45

Introduction

46

Insight into Psychiatric Disorders (Schizophrenia)

46

Awareness and Symptomatology

47

Clinical and Demographic Factors

47

Awareness and Neurocognition

48

Neuroimaging

48

Mood

49

Insight and Awareness in Alzheimer’s Disease

49

Insight and Awareness in Brain Injury

50

Direct Comparison of Insight and Awareness in Patients with Schizophrenia, AD, and Brain Injury

51

Participants

52

Methods

53

Results

53

Between-Group Contrasts

53

Pooled Patient Analysis

55

Summary and Conclusions

56

References

56

Miyoshi_Ch04_O.pdf

62

Visual Hallucinations in Neurodegenerative Disorders

62

Introduction

62

Visual Hallucinations in Synucleinopathies

63

Dementia with Lewy Bodies

63

Epidemiology

63

Factors Associated with VH in DLB

64

Clinical Characteristics of VH in DLB

64

Clinical Impact and Treatment of VH in DLB

65

Parkinson’s Disease

65

Epidemiology

65

Factors Associated with the Presentation of Hallucinations in PD

65

Clinical Characteristics of VH in PD

66

Clinical Impact and Treatment of VH in PD

66

Multiple System Atrophy

67

VH in Tauopathies

67

Alzheimer’s Disease

67

Epidemiology

67

Factors Associated with the Presentation of Hallucinations in AD

68

Clinical Characteristics of VH in AD

68

Clinical Impact and Treatment of VH in AD

68

Progressive Supranuclear Palsy

68

Frontotemporal Dementia

69

VH in Heredodegenerative and Other Neurodegenerative Diseases

69

Conclusions

70

References

70

Miyoshi_Ch05_O.pdf

75

Organic Delusional Syndrome: Tentative Neuropsychological Mechanism of Delusions

75

Introduction

76

Persecutory Delusion and Delusional Perception in PDFTBI

76

Delusional Misidentification Syndrome: Capgras Syndrome

80

Anosognosia and Somatoparaphrenia

82

Conclusion

84

References

85

Miyoshi_Ch06_O.pdf

87

Neurological and Psychological Formsof Amnesia

87

Introduction

87

Transient Neurological Amnesias

89

Transient Global Amnesia

89

Transient Epileptic Amnesia

90

Persistent Neurological Memory Disorders

91

The Korsakoff Syndrome

91

Herpes Encephalitis

93

Confabulation

94

Transient Psychogenic Amnesia

95

Psychogenic Fugue

95

Situation-Specific Amnesia

96

Persistent Psychogenic Amnesia

97

Conclusions

98

References

98

Miyoshi_Ch07_O.pdf

102

The Neuropsychological Aspect of Epilepsy

103

Discussion and Conclusion

107

References

108

Miyoshi_Ch08_O.pdf

110

The Interictal Dysphoric Disorder of Epilepsy

110

Epilepsy and Depression: An Overview

110

Is Depression Associated with Any Specific Epilepsy Syndrome?

112

Is There a Mood Disorder Specific of Epilepsy? The Interictal Dysphoric Disorder

112

Diagnosing Mood Disorders in Patients with Epilepsy

115

Conclusions

117

References

117

Miyoshi_Ch09_O.pdf

120

Neuropsychiatric Symptoms of Seizure Disorders with Special Reference to the Amygdala

120

Introduction

120

The Amygdala

121

The Amygdala in Epilepsy

122

Structural Changes

123

Functional Studies

125

Conclusions

126

References

127

Miyoshi_Ch10_O.pdf

129

Neuropsychiatric Assessment of Traumatic Brain Injury During Acute Neurorehabilitation*

130

Introduction

131

Defining TBI

132

Characterizing TBI Severity

133

Neurobiology of TBI

134

Brain–Behavior Relationships and TBI

136

Posttraumatic Encephalopathy

137

Neuropsychiatric Evaluation of TBI in the Acute Rehabilitation Setting

140

Bedside Assessment Methods

140

Neurodiagnostic Methods

142

Review of Concurrently Prescribed Treatments

144

Conclusion

145

References

146

Miyoshi_Ch11_O.pdf

152

Neuropsychiatric Aspects of Vascular Cognitive Impairment

153

Background

154

Neuropsychiatric Disorders Associated with Cognitive Impairment

154

Alzheimer’s Disease

154

Depression

155

Psychotic Symptoms

155

Cerebrovascular Diseases Associated with Cognitive Impairment and Neuropsychiatric Conditions

156

Stroke

156

Silent Infarcts

158

White Matter Lesions

158

Mixed Pathology

160

Conclusion

161

References

161

Miyoshi_Ch12_O.pdf

167

Neuropsychiatric Complications of Cerebrovascular Disease

167

Introduction

167

Mania

168

Anxiety

169

Apathy

170

Disturbance of the Sleep–Wake Cycle

171

Fatigue

172

Sexual Dysfunction

173

Cognitive Performance

174

Involuntary Emotional Expression Disorder

175

Irritability

176

Psychosis

176

Agitation

177

Depression

177

Conclusion

178

References

178

Miyoshi_Ch13_O.pdf

181

Systemic Inflammation and Cognition in the Elderly

181

Introduction

182

Background

182

Inflammation and Alzheimer’s disease

182

“Inflammaging”

183

Cross-Sectional Studies

195

Longitudinal Studies

196

Discussion

198

Conclusion

199

References

199

Miyoshi_Ch14_O.pdf

202

Diagnosis and Clinical Relevance of Depression and Apathy in Alzheimer’s Disease

203

Depression in Alzheimer’s Disease

204

Diagnosis of Depression in AD

204

Diagnostic Criteria for Depression in AD

204

Frequency of Depression in AD

207

Clinical Correlates of Depression in AD

207

Conclusion

207

Apathy in AD

208

Diagnosis of Apathy in AD

208

Differential Diagnosis of Apathy in AD

210

Frequency of Apathy in AD

210

Clinical Correlates of Apathy in AD

210

Conclusions

211

References

211

Miyoshi_Ch15_O.pdf

214

Cognitive Decline and Treatment of Alzheimer’s Disease

214

Treatment of AD

218

Specific Goals of Treatment

219

Restoring Neuronal Function

219

Preventing Synapse and Cell Death

219

Treatment of the Primary Cognitive Symptoms

219

Cholinergic Agents

220

Acetylcholine Precursors

220

Acetylcholinesterase Inhibitors

220

Glutamate Regulators

221

Antioxidants

221

Antiinflammatory Drugs

222

Estrogen Replacement Therapy

223

Neurotrophic Factors

224

Treatment of Secondary Noncognitive Symptoms

224

New Nonpharmacological Possibilities of Treatment

225

References

225

Miyoshi_Ch16_O.pdf

228

Alzheimer’s Disease in Japan: Current Situation and Issues of the Care for Persons with Dementia

228

Introduction

228

Early Detection and Diagnosis

229

Supporting the Human Rights of Persons with Dementia

233

Issues for the Future

234

References

235

Miyoshi_Ch17_O.pdf

236

AD-FTLD Spectrum: New Understanding of the Neurodegenerative Process from the Study of Risk Genes

236

Genes for AD and FTLD

238

Progranulin and TDP-43

240

Copy Number Variation, miRNA, and Neurodegeneration

241

AD-FTLD Spectrum

242

References

244

Miyoshi_Ch18_O.pdf

247

Dementia with Lewy Bodies

247

Introduction

247

Pathology and Etiology

248

Clinical Features

249

Investigations

250

Diagnostic Criteria

251

References

252

Miyoshi_Ch19_O.pdf

255

Dementia with Lewy Bodies and Parkinson Disease with Dementia Within the Spectrum of Lewy Body Disease

255

Introduction

256

History of PD and DLB

256

DLB and PDD Within the Spectrum of Lewy Body Disease

257

References

258

Miyoshi_Ch20_O.pdf

260

Clinicopathological Characterizationof Frontotemporal Lobar Degeneration

260

Introduction

260

Pick Disease

263

FTLD-LDH

264

FTLD-MND

265

Comments

267

References

268

Miyoshi_Ch21_O.pdf

270

Diffuse Neurofibrillary Tangles with Calcification

270

Introduction

271

Case Presentation

271

Epidemiology of DNTC

273

Characteristics of Clinical Symptoms

273

Pathological Characteristics

274

NFTs

274

Characteristics of Degenerative Tau Protein

275

Electron Microscopy Findings

275

Calcification

275

Cerebrovascular Lesions

276

Lewy Body Pathology

276

Conclusion

276

References

276

Miyoshi_Ch22_O.pdf

278

Ayahuasca: Current Interest in an Ancient Ritual

279

Introduction

279

Description of an Ayahuasca Ceremony

281

Conclusions

283

References

284

Miyoshi_Ch23_O.pdf

285

The Molecular Genetics of Suicide

285

Introduction

285

Molecular Genetics of Suicide

287

Conclusion

294

References

294

Miyoshi_Ch24_O.pdf

296

Brief History and Current Status of the International Neuropsychiatric Association

297

Introduction

297

The Beginning: The First Congress in Seville

298

The Reorganization: The Second Congress in Toronto

300

The Springboard: The Third Congress in Kyoto

302

The Jump: The Fourth Congress in Buenos Aires

303

The Collaborations: The Fifth Congress in Athens

304

The Widening: The Sixth Congress in Sydney

306

The Latest: The Seventh Congress in Cancun

307

Regional Activities

308

The Coming INA Meetings

308

Current Status of the INA

308

Officers and INA Office

308

Executive Committee

309

International Committee

309

Awards

310

Journal

310

Relationships to National Neuropsychiatric Associations

310

Future Direction

311

Miyoshi_Ch25_O.pdf

312

Core Curriculum in Neuropsychiatry of the International Neuropsychiatric Association*

312

Background

313

Goals of the Training Program

313

Structure of the NP Training Program

314

Objectives

315

Attitude Objectives

315

Knowledge Objectives

315

Skills Objectives

318

A Survey of Required Competencies in Neuropsychiatry

319

Core Skills Module

320

Specific Competencies

320

Knowledge Base in Neuroscience

320

Clinical Skills in Neuropsychiatry

320

Critical Thinking in Neuropsychiatry: Research and Scholarship

324

Specific Modules

324

Module 2.1: Cognitive Disorders

324

Specific Competencies

324

Diagnostic Techniques

325

Be familiar with the main principles involved in the management and treatment of cognitive disorders and of dementias

325

How Taught

326

How Assessed

326

Module 2.2: Seizure Disorders

326

Specific Competencies

326

Module 2.3: Movement Disorders

328

Specific Competencies

328

Suggested Learning Methods

328

Suggested Assessment Method: Clinic Logbook

329

Module 2.4: Traumatic Brain Injury

329

Clinical Settings

329

Specific Competencies

329

Suggested Learning Methods

329

Module 2.5: Secondary Psychiatric Syndromes and Delirium

330

Clinical Settings

330

Specific Competencies

330

Suggested Learning Methods

330

Module 2.6: Substance-Induced Neuropsychiatric Syndromes

330

Clinical Settings

330

Specific Competencies

330

Suggested Learning Methods

331

Module 2.7: Attentional and Dysexecutive Syndromes (Including Adult ADHD)

331

Clinical Settings

331

Specific Competencies

331

Suggested Learning Methods

331

Module 2.8: General Hospital Liaison Neuropsychiatry

332

Key Competencies

332

Learning and Assessment Methods

332

Module 2.9: Developmental Neuropsychiatry

333

Preamble

333

Skills in Developmental Neuropsychiatry

334

Specific Competencies

334

Learning and Assessment Methods

335

Module 2.10: Sleep Disorders

336

Specific Competencies

336

Diagnostic Techniques

337

Management

337

Suggested Learning Methods

337

Suggested Assessment Methods

338

Module 2.11: Rehabilitation Neuropsychiatry

338

Clinical Settings

338

Knowledge

338

Skills

338

Learning and Assessment Methods

339

Module 2.12: Forensic Neuropsychiatry

339

Key Competencies

339

Learning and Assessment Methods

340

Recommended Reading

340

Miyoshi_Index_O.pdf

342